Help or hindrance?
Agreement I do not Agree Body There are several concerns with this research paper, whose authors are mostly employees of Prostate Cancer UK (PCUK) (1). They describe various activities in terms of…
Read the full articleYou might also wanna read
Is investing in medicines harming the health of the UK population?
A recent study published in the Lancet has disputed the existing decision-making threshold used by NICE. The authors argue that allowing NHS
Updated Cochrane Review Finds Modest Prostate Cancer Mortality Reduction from PSA Screening, But Overdiagnosis Risks Remain
New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress the gains are
Prostate cancer screening debate continues as experts seek more accurate detection methods
Experts are trying to find the best way to screen for prostate cancer, since blood tests alone are not accurate enough for most men.
Was Giving My Opinion to a Non-Patient Worth the Risk?
My cellphone rang in the mid-afternoon. I’m a mostly retired rheumatologist in my mid-70s. I’m a bit of a hermit who does not get many phone
Effect of an in-consult patient decision aid on decisional quality and involvement for patients with severe hip or knee osteoarthritis: a multicenter, cluster randomized controlled trial
Background and purpose: Shared decision-making (SDM) is important in managing patients with severe hip and knee osteoarthritis, where treatm
Critics question consent, clinical utility, and industry influence in UK's Our Future Health programme
The UK’s flagship health research programme promises breakthroughs, but beneath an NHS branded facade, critics are asking who really benefit

Comments
Sign in to join the conversation.
No comments yet. Be the first.